Screener
Sionna Therapeutics SION Available-for-Sale Debt Securities
Available-for-Sale Debt Securities at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $63,324 | $58,451 |
| Marketable securities, current | 152,826 | 177,431 |
| Prepaid expenses and other current assets | 4,809 | 5,537 |
| Total current assets | 220,959 | 241,419 |
| Property and equipment, net | 2,071 | 2,225 |
| Marketable securities, noncurrent | 73,781 | 74,420 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's available-for-sale debt securities?
- Sionna Therapeutics (SION) reported available-for-sale debt securities of $152.83M in Q1 2026.
- How has Sionna Therapeutics's available-for-sale debt securities changed year-over-year?
- Sionna Therapeutics's available-for-sale debt securities decreased by 18.3% year-over-year, from $186.97M to $152.83M.
- What does available-for-sale debt securities mean?
- This metric represents the fair market value of debt instruments held by the company that are neither classified as held-to-maturity nor as trading securities. It reflects the portion of the company's liquid assets invested in interest-bearing securities that can be sold to meet operational or strategic funding requirements. Changes in the valuation of these securities are typically recorded in other comprehensive income, providing insight into the company's treasury management and liquidity buffer.
Ask your AI about Sionna Therapeutics's available-for-sale debt securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude